GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
NANOG | 20857 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5461 | 34168259
|
SOX2 | 11195 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5695 | 34168259
|
HNRNPAB | 5034 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.36 | 0.0032 | 34168259
|
LDHA | 6535 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.36 | 0.0053 | 34168259
|
VDAC2 | 12672 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.36 | 0.0011 | 34168259
|
HDHA | NA | HTM/LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 34168259
|
HNRNPAB | 5034 | HTM/LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics and Western Blotting | Down | 0.36 | 0.0032 | 34168259
|
LDHA | 6535 | HTM/LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics and Western Blotting | Down | 0.36 | 0.0053 | 34168259
|
VDAC2 | 12672 | HTM/LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 34168259
|
CCNB1 | 1579 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR | NA | 0.2 | 0.0053 | 34168259
|
FZD2 | 4040 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR | NA | 0.2 | 0.0021 | 34168259
|
POU5F1 | 9221 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR | NA | 0.2 | 0.6448 | 34168259
|
ACO2 | 118 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
AGR2 | 328 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259
|
AHNAK | 347 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
ALB | 399 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
ALDH2 | 404 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
ANPEP | 500 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0117 | 34168259
|
ANXA11 | 535 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
ANXA13 | 536 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
ANXA2 | 537 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
ANXA3 | 541 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0085 | 34168259
|
ANXA7 | 545 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
APEX1 | 587 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
API5 | 594 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
APMAP | 13238 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
ARF3 | 654 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
ARF4 | 655 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
ARHGEF19 | 26604 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
ARL6IP5 | 16937 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
ARPC2 | 705 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
ARPC5L | 23366 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
ASPH | 757 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
ATIC | 794 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
ATP1A1 | 799 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
ATP5ME | 846 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
ATP5MF | 848 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
ATP5PB | 840 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
BANF1 | 17397 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
BDH1 | 1027 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
BZW2 | 18808 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
C1QBP | 1243 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
C2orf72 | 27418 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
CALB2 | 1435 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
CAND1 | 30688 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
CAPZB | 1491 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
CCAR2 | 23360 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
CCT2 | 1615 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
CCT4 | 1617 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
CDC42 | 1736 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
COX7A2 | 2288 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
CPSF6 | 13871 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
CPVL | 14399 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
CSE1L | 2431 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
CSTB | 2482 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
CTNNBL1 | 15879 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
CTNND1 | 2515 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
CTSD | 2529 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
CUTA | 21101 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
CYB5R3 | 2873 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
CYC1 | 2579 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
CYCS | 19986 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
CYSTM1 | 30239 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
DDT | 2732 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
DDX18 | 2741 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
DDX21 | 2744 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
DERL1 | 28454 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
DHCR24 | 2859 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
DHRS9 | 16888 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 34168259
|
DHX9 | 2750 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
DPY30 | 24590 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
DPYSL2 | 3014 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
DSP | 3052 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
ECH1 | 3149 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
EIF2AK2 | 9437 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
EIF4A1 | 3282 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
EPHX1 | 3401 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
ERGIC1 | 29205 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
FARSB | 17800 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
FBP1 | 3606 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
FIS1 | 21689 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
FKBP1A | 3711 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
FSCN1 | 11148 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 34168259
|
FUS | 4010 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
G3BP1 | 30292 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
GART | 4163 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259
|
GFPT1 | 4241 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
GLS | 4331 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
GLUD1 | 4335 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
GNA13 | 4381 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
GNAI1 | 4384 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
GOLT1B | 20175 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
GOT2 | 4433 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
GPD2 | 4456 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
GPI | 4458 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
GSTP1 | 4638 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
GTF2I | 4659 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
H1-0 | 4714 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
H1-2 | 4716 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
H1-3 | 4717 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
H1-5 | 4719 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
H2AC18 | 4736 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
H2AC21 | 20508 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
H2AC6 | 4733 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
H2BC12 | 13954 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
H2BC13 | 4748 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
H2BC21 | 4760 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
H3-4 | 4778 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
HADHA | 4801 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
HADHB | 4803 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
HBE1 | 4830 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
HIBCH | 4908 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
HK1 | 4922 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
HMGB1 | 4983 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
HNRNPDL | 5037 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
HNRNPK | 5044 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
HNRNPU | 5048 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
HP1BP3 | 24973 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
HPCAL1 | 5145 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
HSD17B12 | 18646 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
HSPA5 | 5238 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0117 | 34168259
|
HSPA6 | 5239 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
HSPA9 | 5244 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
IGF2BP2 | 28867 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
IGF2BP3 | 28868 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
IL18 | 5986 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
ILF2 | 6037 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
ITGB4 | 6158 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259
|
KARS1 | 6215 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
KPNA4 | 6397 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
KRT18 | 6430 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259
|
KRT79 | 28930 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
KRT9 | 6447 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
LAMB3 | 6490 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 34168259
|
LGALS3BP | 6564 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
LRRC59 | 28817 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
MDH1 | 6970 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
ME3 | 6985 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
MGST3 | 7064 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
MOGS | 24862 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
MRPL28 | 14484 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
MSN | 7373 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
MVP | 7531 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
NAXE | 18453 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
NCEH1 | 29260 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
NIPSNAP1 | 7827 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
NOLC1 | 15608 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
NOP56 | 15911 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
NPC1 | 7897 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
NQO1 | 2874 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
OCIAD2 | 28685 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
PAFAH1B2 | 8575 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
PARK7 | 16369 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
PCK2 | 8725 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
PGAM1 | 8888 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
PGD | 8891 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
PGRMC2 | 16089 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
PLS1 | 9090 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
PPP1CA | 9281 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
PRKAG1 | 9385 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
PSAP | 9498 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
PSMA3 | 9532 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
PSMA5 | 9534 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
PSMC5 | 9552 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
PSME1 | 9568 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
PSME2 | 9569 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
RAB1A | 9758 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
RALY | 15921 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
RALYL | 27036 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
RAP1A | 9855 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RBM39 | 15923 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RPL11 | 10301 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
RPL13A | 10304 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
RPL14 | 10305 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RPL17 | 10307 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RPL24 | 10325 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RPL4 | 10353 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
RPL6 | 10362 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
RPL7 | 10363 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
RPL7A | 10364 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RPL9 | 10369 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
RPLP1 | 10372 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RPN2 | 10382 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
RPS10 | 10383 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RPS16 | 10396 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
RPS2 | 10404 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
RPS29 | 10419 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RPS3 | 10420 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
RPS3A | 10421 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
RPS7 | 10440 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
RSL1D1 | 24534 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
RTN4 | 14085 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
S100A10 | 10487 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
S100A16 | 20441 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
SCARB2 | 1665 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
SDHA | 10680 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259
|
SEPTIN6 | 15848 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
SEPTIN7 | 1717 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
SET | 10760 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
SF3A1 | 10765 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
SFPQ | 10774 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
SFXN1 | 16085 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
SHMT2 | 10852 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
SLC25A1 | 10979 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
SLC25A10 | 10980 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
SLC25A3 | 10989 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
SLC25A6 | 10992 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
SLC2A1 | 11005 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
SLC3A2 | 11026 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0085 | 34168259
|
SOD2 | 11180 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259
|
SRFBP1 | 26333 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
SRP14 | 11299 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
SRSF10 | 16713 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
STMN1 | 6510 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
STT3A | 6172 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
SUB1 | 19985 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
SUMF2 | 20415 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
SYNCRIP | 16918 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
TALDO1 | 11559 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
TARDBP | 11571 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
TGM2 | 11778 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
TMPO | 11875 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
TOMM40 | 18001 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
TPI1 | 12009 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
TPR | 12017 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
TSPAN8 | 11855 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
TSPO | 1158 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
TST | 12388 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
TUBA1C | 20768 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
TUBA4A | 12407 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
TXNDC17 | 28218 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
U2AF2 | 23156 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
UGDH | 12525 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
UGT1A10 | 12531 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
VAT1 | 16919 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
VCL | 12665 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
VCP | 12666 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
VKORC1L1 | 21492 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
WARS1 | 12729 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
XPO1 | 12825 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
XRCC5 | 12833 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
XRCC6 | 4055 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
YWHAG | 12852 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
YWHAQ | 12854 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|